false
0001358190
0001358190
2026-04-16
2026-04-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April
16, 2026
IT TECH PACKAGING, INC.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
| 001-34577 |
|
20-4158835 |
| (Commission File Number) |
|
(IRS Employer
Identification No.) |
|
Science Park, Juli Road
Xushui District, Baoding City
Hebei Province, People’s Republic of China |
|
072550 |
| (Address of principal executive offices) |
|
(Zip Code) |
(86) 312-8698215
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.001 per share |
|
ITP |
|
NYSE American LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On April 16, 2026, IT Tech Packaging, Inc., a Nevada corporation (the
“Company”), received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”)
stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”)
due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2025 (the “Delinquent Report”)
by the filing due date of April 15, 2026 (the “Filing Delinquency”).
The Company is now subject to the procedures and requirements set forth
in Section 1007 of the NYSE American Company Guide (the “Company Guide”). Within five days of the date of the Filing Delinquency
Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release
disclosing the occurrence of the Filing Delinquency, the reason for the Filing Delinquency and, if known, the anticipated date such Filing
Delinquency will be cured via the filing or refiling of the applicable report, as the case may be. The NYSE American Notice has no immediate
effect on the listing or trading of the Company’s common stock on NYSE American.
During the six-month period from the date of the Filing Delinquency
(the “Initial Cure Period”), the NYSE will monitor the Company and the status of the Delinquent Report and any subsequent
delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to cure the Filing
Delinquency within the Initial Cure Period, the NYSE may, in the NYSE’s sole discretion, allow the Company’s securities to
be traded for up to an additional six-month period (the “Additional Cure Period”) depending on the Company’s specific
circumstances. If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence
in accordance with the procedures set out in Section 1010 of the Company Guide. If the NYSE determines that an Additional Cure Period
of up to six months is appropriate and the Company fails to file its Delinquent Report and any subsequent delayed filings by the end of
that period, suspension and delisting procedures will generally commence.
Notwithstanding the foregoing, however, the NYSE may in its sole discretion
decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time
during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may
be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision
of the Company Guide, including if the NYSE believes, in the NYSE’s sole discretion, that continued listing and trading of the Company’s
securities on the NYSE is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide.
Reference is made to the Company’s Notification of Late Filing
on Form 12b-25 (filed with the SEC on March 31, 2026), which described the circumstances leading to the late filing of the Delinquent
Report. The Delinquent Report could not be filed within the prescribed time period due to the fact that the Company was unable to finalize
its financial results as well as the disclosure requirements of the Delinquent Report without unreasonable expense or effort. As a result,
the Company could not solicit and obtain the necessary review of the Delinquent Report in a timely fashion prior to the due date of the
Delinquent Report. Additional time is needed by the Company to complete its review of the financial statements included in the Delinquent
Report to ensure a complete, accurate Delinquent Report. The Company intends to file the Delinquent Report as soon as practicable and
in any event within the six-month period.
The Company intends to regain compliance with the NYSE American continued
listing standards. There can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing
standards.
Item 7.01. Regulation FD Disclosure.
On April 20, 2026, the Company issued a press release announcing its
receipt of the NYSE American Notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information under this Item 7.01, including Exhibit 99.1 hereto,
is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form
8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto,
is material or that the dissemination of such information is required by Regulation FD.
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains “forward-looking
statements.” Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute
forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “if,”
“may,” “should,” “expects,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential” or “continue” or the
negative of these terms or other comparable terminology and include statements regarding the NYSE American Notice and whether the
Company will regain compliance with the NYSE American’s continued listing standards. These forward-looking statements are
based on information currently available to the Company’s management as well as estimates and assumptions made by its
management and are subject to risks and uncertainties that may cause actual results, performance or developments to differ
materially from those contained in the statements. These statements are only predictions and involve known and unknown risks,
uncertainties and other factors, which may cause the Company’s or its industry’s actual results, levels of activity or
performance to be materially different from any future results, levels of activity or performance expressed or implied by these
forward-looking statements. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the
Company does not undertake an obligation to update these forward-looking statements after such date.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are filed herewith:
Exhibit
Number |
|
Description |
| |
|
|
| 99.1 |
|
Press Release dated April 20, 2026. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
IT TECH PACKAGING, INC. |
| |
|
|
|
| Date: April 20, 2026 |
By: |
/s/ Zhenyong Liu |
| |
|
Name: |
Zhenyong Liu |
| |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
IT Tech Packaging, Inc. Announces Receipt of
Notice of Non-Compliance
with NYSE Continued Listing Requirements
BAODING, China, April 20, 2026–(PRNewswire)– IT
Tech Packaging Inc. (NYSE American: ITP) (“IT Tech Packaging” or the “Company”), a leading manufacturer and distributor
of diversified paper products in North China, received an official notice of noncompliance (the “NYSE American Notice”)
from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards
(the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended
December 31, 2025 (the “Delinquent Report”) by the filing due date of April 15, 2026 (the “Filing Delinquency”).
The Company is now subject to the procedures and requirements set forth
in Section 1007 of the NYSE American Company Guide (the “Company Guide”). Within five days of the date of the Filing Delinquency
Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release
disclosing the occurrence of the Filing Delinquency, the reason for the Filing Delinquency and, if known, the anticipated date such Filing
Delinquency will be cured via the filing or refiling of the applicable report, as the case may be. The NYSE American Notice has no immediate
effect on the listing or trading of the Company’s common stock on NYSE American.
During the six-month period from the date of the Filing Delinquency
(the “Initial Cure Period”), the NYSE will monitor the Company and the status of the Delinquent Report and any subsequent
delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to cure the Filing
Delinquency within the Initial Cure Period, the NYSE may, in the NYSE’s sole discretion, allow the Company’s securities to
be traded for up to an additional six-month period (the “Additional Cure Period”) depending on the Company’s specific
circumstances. If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence
in accordance with the procedures set out in Section 1010 of the Company Guide. If the NYSE determines that an Additional Cure Period
of up to six months is appropriate and the Company fails to file its Delinquent Report and any subsequent delayed filings by the end of
that period, suspension and delisting procedures will generally commence.
Notwithstanding the foregoing, however, the NYSE may in its sole discretion
decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time
during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may
be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision
of the Company Guide, including if the NYSE believes, in the NYSE’s sole discretion, that continued listing and trading of the Company’s
securities on the NYSE is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide.
Reference is made to the Company’s Notification of Late Filing
on Form 12b-25 (filed with the SEC on March 31, 2026), which described the circumstances leading to the late filing of the Delinquent
Report. The Delinquent Report could not be filed within the prescribed time period due to the fact that the Company was unable to finalize
its financial results as well as the disclosure requirements of the Delinquent Report without unreasonable expense or effort. As a result,
the Company could not solicit and obtain the necessary review of the Delinquent Report in a timely fashion prior to the due date of the
Delinquent Report. Additional time is needed by the Company to complete its review of the financial statements included in the Delinquent
Report to ensure a complete, accurate Delinquent Report. The Company intends to file the Delinquent Report as soon as practicable and
in any event within the six-month period.
The Company intends to regain compliance with the NYSE American continued
listing standards. There can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing
standards.
About IT Tech Packaging, Inc.
Founded in 1996, IT Tech Packaging, Inc. is a
leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with
the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper,
offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is
located strategically close the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one
of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For
more information, please visit: www.itpackaging.cn.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995, as amended. Certain of these forward-looking statements can be identified by
the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,”
“assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions.
Such statements may include, but are not limited to, statements regarding the Company’s plan to file the Delinquent Report within
the Initial Cure Period to regain compliance with the NYSE American continued listing standards. Forward-looking statements are statements
that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results
to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, the Company’s
ability to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards,
and other risks and uncertainties indicated from time to time in filings with the Securities and Exchange Commission (“SEC”),
including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, under the heading “Risk Factors,”
and other documents the Company has filed, or will file, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking
statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any
updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with
respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contacts:
At the Company Email:
ir@itpackaging.cn
Tel: +86 0312 8698215